Gemcitabine for Injection USP 200 mg

Gemcitabine for Injection USP 200 mg

Product Code : 08

Product Description

Our team of experienced professionals help us to manufacture and export a quality range of Gemcitabine Injection. For cell lung cancer and breast cancer treatment these drugs are highly used in medical institutions and hospitals. To formulate the drugs, we use best quality of compounds, sourced from the most authentic vendors. The Gemcitabine for Injection USP 200 mg is packed in air proof packaging materials and offered to the clients at the reasonable prices.

Features:

Instant relief

Non toxic

Precise Composition

Gemcitabine Injection USP 200 mg (Lyophilized)

Indications :

Pancreatic Cancer

Non-Small Cell Lung Cancer

Breast Cancer

Ovarian Cancer

Dosage :

Single-Agent Use : Pancreatic Cancer -Gemcitabine should be administered by intravenous infusion at a dose of 1000 mg/m2 over 30 minutes once weekly for up to 7 weeks (or until toxicity necessitates reducing or holding a dose), followed by a week of rest from treatment.

Subsequent cycles should consist of infusions once weekly for 3 consecutive weeks out of every 4 weeks.

Combination Use Non-Small Cell Lung Cancer : Two schedules have been investigated and the optimum schedule has not been determined. With the 4-week schedule, Gemcitabine should be administered intravenously at 1000 mg/m2 over 30 minutes on days 1, 8 and 15 of each 28-day cycle.

Cisplatin should be administered intravenously at 100 mg/m2 on day 1 after the infusion of Gemcitabine.With the 3-week schedule, Gemcitabine should be administered intravenously at 1250 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle.

Cisplatin at a dose of 100 mg/m2 should be administered intravenously after the infusion of Gemcitabine on day 1.

Breast Cancer : Gemcitabine should be administered intravenously at a dose of 1250 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle. Paclitaxel should be administered at 175 mg/m2 on day 1 as a 3-hour intravenous infusion before Gemcitabine administration.

Ovarian Cancer : Gemcitabine should be administered intravenously at a dose of 1000 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle. Carboplatin AUC 4 should be administered intravenously on day 1 after Gemcitabine administration.